Why does antagonising D2 receptors reduce positive schizophrenic symptoms?

  • Thread starter Thread starter foldedelephants
  • Start date Start date
  • Tags Tags
    Positive
AI Thread Summary
Antagonizing D2 receptors can reduce positive symptoms of schizophrenia, despite the common understanding that excessive dopamine signaling in the mesolimbic system contributes to these symptoms. The discussion highlights the existence of two types of D2 receptors: D2 long and D2 short. While antagonism of D2 short receptors may lead to increased activity, typical antipsychotics primarily target D2 long receptors. Atypical antipsychotics also affect D2 autoreceptors, influencing dopamine responsiveness. Excessive D2 receptor activation is linked to the misinterpretation of ordinary events, contributing to disorganized thoughts and psychotic symptoms. Current strategies focus on reducing dopamine activity to alleviate positive symptoms, while research into other neurotransmitters, such as glutamate and serotonin, continues to evolve. The lack of comprehensive information on D2 receptor types in mainstream sources like Wikipedia and Google is noted as an area for improvement.
foldedelephants
Messages
3
Reaction score
0
The title should say: why does antagonising D2 receptors reduce positive schizophrenic symptoms?
It doesn't make sense to me. If positive schizophrenic symptoms are caused by too much dopamine signalling in the mesolimbic system, and D2 receptors hyperpolarise the post synaptic neuron when activated, how does antagonising the D2 receptor reduce activity within the mesolimbic system?
 
Biology news on Phys.org
The thing your missing is that there are two types of D2 receptors. There's D2 long and D2 short. Antagonism of only D2 short would result in your conclusion; but, most typical AP's work to antagonize D2 long receptors also. Also keep in mind that the newer atypical antipsychotics also target D2 autoreceptors, leading to reduced responsiveness of dopamine itself to the postsynaptic receptors or heightened response when there are low levels of DA (think aripiprazole).

As to answering your OP's question. Excessive activation of D2 receptors results in attaching significance to mundane and ordinary events leading often to the characteristic disorganized thoughts and psychotic symptoms seen in schizophrenics. Although there is some discussion currently taking place in the psychiatric and neurological community, it's still thought that reducing excessive dopamine activity is the best strategy for reducing positive symptoms (glutamate is being heavily investigated due to also being the most prominent excitatory neurotransmitter). There are other neurotransmitters at play, such as 5-HT, and the 5-HT2A&B&C receptors along with dysfunctions in the GABA system to moderate/regulate the aberrant excitatory activity seen in schizophrenics, which are still being investigated in relation to schizophrenia.
 
Last edited:
  • Like
Likes Fervent Freyja
I'm surprised Wikipedia and Google have such lackluster information about the difference between D2-Long and D2-Short receptors, I suppose that could be worked on.
 
Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S. According to articles in the Los Angeles Times, "Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S.", and "Kissing bugs bring deadly disease to California". LA Times requires a subscription. Related article -...
I am reading Nicholas Wade's book A Troublesome Inheritance. Please let's not make this thread a critique about the merits or demerits of the book. This thread is my attempt to understanding the evidence that Natural Selection in the human genome was recent and regional. On Page 103 of A Troublesome Inheritance, Wade writes the following: "The regional nature of selection was first made evident in a genomewide scan undertaken by Jonathan Pritchard, a population geneticist at the...
Back
Top